Close

BSD Medical (BSDM) Reports Encouraging Data from BSD-2000 Study

February 5, 2013 9:17 AM EST Send to a Friend
BSD Medical Corporation (Nasdaq: BSDM) announced the publication of results from a clinical study on advanced pancreatic cancer using the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login